Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Taskforce
DS Cooper, GM Doherty, BR Haugen, RT Kloos… - Thyroid, 2006 - liebertpub.com
THYROID NODULES are a common clinical problem. Epidemiologic studies have shown
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …
BRAF mutation in thyroid cancer
M Xing - Endocrine-related cancer, 2005 - erc.bioscientifica.com
Genetic alteration is the driving force for thyroid tumorigenesis and progression, based upon
which novel approaches to the management of thyroid cancer can be developed. A recent …
which novel approaches to the management of thyroid cancer can be developed. A recent …
18F-FDG PET/CT Imaging In Oncology
A Almuhaideb, N Papathanasiou… - Annals of Saudi …, 2011 - annsaudimed.net
Accurate diagnosis and staging are essential for the optimal management of cancer
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …
The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk
N Kwong, M Medici, TE Angell, X Liu… - The Journal of …, 2015 - academic.oup.com
Introduction: Although advancing age is known to influence the formation of thyroid nodules,
the precise relationship remains unclear. Furthermore, it is uncertain whether age influences …
the precise relationship remains unclear. Furthermore, it is uncertain whether age influences …
European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer …
M Luster, C Aktolun, I Amendoeira, M Barczyński… - Thyroid, 2019 - liebertpub.com
Background: The American Thyroid Association (ATA) management guidelines for patients
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …
Anaplastic thyroid carcinoma: treatment outcome and prognostic factors
E Kebebew, FS Greenspan, OH Clark, KA Woeber… - Cancer, 2005 - Wiley Online Library
BACKGROUND Anaplastic thyroid carcinoma (ATC) is rare but is one of the most aggressive
human malignancies. Several prognostic factors have been observed in patients with ATC …
human malignancies. Several prognostic factors have been observed in patients with ATC …
Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration
K Boelaert, J Horacek, RL Holder… - The Journal of …, 2006 - academic.oup.com
Context: Thyroid nodules and goiter are common, and fine-needle aspiration biopsy (FNAB)
is the first investigation of choice in distinguishing benign from malignant disease. Objective …
is the first investigation of choice in distinguishing benign from malignant disease. Objective …
Heterogeneity of thyroid cancer
E Chmielik, D Rusinek, M Oczko-Wojciechowska… - Pathobiology, 2018 - karger.com
There are 5 main histological types of thyroid cancers (TCs): papillary, follicular (also known
as differentiated), poorly differentiated, anaplastic (the most aggressive form), and medullary …
as differentiated), poorly differentiated, anaplastic (the most aggressive form), and medullary …
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer
MA Kouvaraki, SE Shapiro, BD Fornage… - Surgery, 2003 - Elsevier
BACKGROUND: Cervical recurrence occurs in up to 30% of patients with differentiated
thyroid carcinoma. We retrospectively compared preoperative transcutaneous …
thyroid carcinoma. We retrospectively compared preoperative transcutaneous …
Phase II trial of sorafenib in advanced thyroid cancer
V Gupta-Abramson, AB Troxel, A Nellore… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Given the molecular pathophysiology of thyroid cancer and the spectrum of kinases
inhibited by sorafenib, including Raf kinase, vascular endothelial growth factor receptors …
inhibited by sorafenib, including Raf kinase, vascular endothelial growth factor receptors …